Chembio Invested Capital Trend from 2010 to 2022

CEMI
 Stock
  

USD 0.86  0.01  1.18%   

Chembio Diagnostics Invested Capital is increasing over the last several years with slightly volatile swings. Invested Capital is estimated to finish at about 56.1 M this year. During the period from 2010 to 2022 Chembio Diagnostics Invested Capital regressed destribution of quarterly values had coefficient of variationof 85.84 and r-squared of  0.66. Chembio Diagnostics Operating Expenses is most likely to increase significantly in the upcoming years. The last year's value of Operating Expenses was reported at 44.38 Million. The current Selling General and Administrative Expense is estimated to increase to about 26.8 M, while Consolidated Income is projected to decrease to (34.8 M).
  
Check Chembio Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Chembio main balance sheet or income statement drivers, such as Direct Expenses of 37.2 M, Cost of Revenue of 28.6 M or Gross Profit of 13.3 M, as well as many exotic indicators such as Interest Coverage of 890, Long Term Debt to Equity of 0.56 or Calculated Tax Rate of 46.46. Chembio financial statements analysis is a perfect complement when working with Chembio Diagnostics Valuation or Volatility modules. It can also supplement Chembio Diagnostics' financial leverage analysis and stock options assessment as well as various Chembio Diagnostics Technical models . Continue to the analysis of Chembio Diagnostics Correlation against competitors.

Chembio Diagnostics Quarterly Invested Capital

45.29 Million

Chembio Invested Capital Breakdown

Showing smoothed Invested Capital of Chembio Diagnostics with missing and latest data points interpolated. Invested capital represents the total cash investment that shareholders and debt holders have contributed to Chembio Diagnostics. There are two different methods for calculating Chembio Diagnostics invested capital: operating approach and financing approach. Understanding Chembio Diagnostics invested capital allows investors to calculate measures of performance such as return on invested capital or return on capital employed. Invested capital is an input into the calculation of [ROIC]; and is calculated as: Total Debt plus Total Assets minus Goodwill and Intangible Assets minus Cash and Equivalents minus Current Liabilities. Please note this calculation method is subject to change.Chembio Diagnostics' Invested Capital historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Chembio Diagnostics' overall financial position and show how it may be relating to other accounts over time.
Invested Capital10 Years Trend
Increasing
Slightly volatile
   Invested Capital   
Share
       Timeline  

Chembio Invested Capital Regression Statistics

Arithmetic Mean 22,570,195
Geometric Mean 16,396,130
Coefficient Of Variation 85.84
Mean Deviation 16,916,861
Median 12,184,575
Standard Deviation 19,373,801
Range 49,576,343
R-Value 0.81
R-Squared 0.66
Significance 0.00077803
Slope 4,032,116

Chembio Invested Capital History

201210.7 M
201310.2 M
201414.9 M
201512.2 M
20166.6 M
20176.6 M
201813.4 M
201946.8 M
202045.3 M
202152 M
202256.1 M

Other Fundumenentals of Chembio Diagnostics

Chembio Diagnostics Invested Capital component correlations

About Chembio Diagnostics Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Chembio Diagnostics income statement, its balance sheet, and the statement of cash flows. Chembio Diagnostics investors use historical funamental indicators, such as Chembio Diagnostics's Invested Capital, to determine how well the company is positioned to perform in the future. Although Chembio Diagnostics investors may use each financial statement separately, they are all related. The changes in Chembio Diagnostics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Chembio Diagnostics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Chembio Diagnostics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Chembio Diagnostics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Return on Invested Capital(0.59) (0.61) 
Invested Capital52 M56.1 M
Invested Capital Average52.2 M56.4 M
Market Capitalization34.3 M53.6 M
Working Capital39.9 M43.1 M
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, lassa, marburg, leptospirosis, rickettsia, and Burkholderia diseases. The company sells its products under the STAT-PAK, SURE CHECK, STAT VIEW, and DPP trademarks, as well as sells its products directly through distributors to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medical professionals, and retail establishments in the United States and internationally. It has collaboration agreements with Bill Melinda Gates Foundation, The Paul G. Allen Family Foundation, The Oswaldo Cruz Foundation, and the Foundation for Innovative New Diagnostics, as well as U.S. government agencies, such as Centers for Disease Control and Prevention, the Biomedical Advanced Research and Development Authority of the U.S. Department of Health and Human Services, and the U.S. Department of Agriculture. Chembio Diagnostics, Inc. was founded in 1985 and is headquartered in Hauppauge, New York.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Chembio Diagnostics without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Piotroski F Score Now

   

Piotroski F Score

Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
All  Next Launch Module

Pair Trading with Chembio Diagnostics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chembio Diagnostics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chembio Diagnostics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Chembio Diagnostics

0.71AXDXAccelerate Diagnosti Earnings Call  TomorrowPairCorr

Moving against Chembio Diagnostics

0.56ALRNAileron Therapeutics Earnings Call  TomorrowPairCorr
0.55GTHGenetron Holdings Earnings Call  Next WeekPairCorr
0.54ABCAmerisourcebergen Corp Fiscal Year End 3rd of November 2022 PairCorr
The ability to find closely correlated positions to Chembio Diagnostics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Chembio Diagnostics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Chembio Diagnostics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Chembio Diagnostics to buy it.
The correlation of Chembio Diagnostics is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Chembio Diagnostics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Chembio Diagnostics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Chembio Diagnostics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to the analysis of Chembio Diagnostics Correlation against competitors. Note that the Chembio Diagnostics information on this page should be used as a complementary analysis to other Chembio Diagnostics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Complementary Tools for Chembio Stock analysis

When running Chembio Diagnostics price analysis, check to measure Chembio Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chembio Diagnostics is operating at the current time. Most of Chembio Diagnostics' value examination focuses on studying past and present price action to predict the probability of Chembio Diagnostics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chembio Diagnostics' price. Additionally, you may evaluate how the addition of Chembio Diagnostics to your portfolios can decrease your overall portfolio volatility.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Is Chembio Diagnostics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chembio Diagnostics. If investors know Chembio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chembio Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
25.7 M
Quarterly Revenue Growth YOY
0.42
Return On Assets
-0.3
Return On Equity
-2.06
The market value of Chembio Diagnostics is measured differently than its book value, which is the value of Chembio that is recorded on the company's balance sheet. Investors also form their own opinion of Chembio Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Chembio Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chembio Diagnostics' market value can be influenced by many factors that don't directly affect Chembio Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chembio Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine Chembio Diagnostics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chembio Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.